BORA (Aurora Kinase A Activator) is a conserved mitotic regulator essential for activating Aurora kinase A (AURKA) during cell cycle progression. At the molecular level, BORA functions as a scaffolding protein that facilitates AURKA-dependent activation of Polo-like kinase 1 (PLK1), a critical event for mitotic entry 1. BORA itself is activated through phosphorylation: Cyclin B/Cdk1 phosphorylates BORA at its N-terminal region during mitotic onset 1, and more recently, cAMP-dependent protein kinase (PKA) has been identified as an upstream regulator that phosphorylates BORA to enable its interaction with AURKA during G2 phase 2. This PKA-BORA-AURKA-PLK1 cascade represents a critical trigger for G2/M transition and is essential for mitotic entry following DNA damage checkpoint recovery 2. Dysregulation of this pathway has implications in cancer biology, as AURKA is frequently amplified in human cancers including breast cancer, and BORA's role in AURKA activation contributes to this oncogenic process 3. Clinically, understanding BORA function is relevant for developing mitotic checkpoint controls and potential therapeutic interventions targeting aberrant cell cycle progression in cancer cells.